Currently modest, yes. Don't forget it is a pioneering field (stem cell science). Banking success is and will be dependent on research success. The more common and definite stem cell cures become, the more demand there will be for stem cells to be available. It's a pretty logical conclusion to make. And ultimately this is the healthcare industry we are talking about. That is huge money. Who would say otherwise?
Market Data 
Markets 
AI
